Who are phytomenadione's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Destriol, Rocephin, Menadion, Rifadin, Bromocriptin, Testosteron.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/phytomenadione.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

phytomenadione — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

phytomenadione (phytomenadione) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Cardiovascular.

phase 2 Alpha-synuclein Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

phytomenadione (phytomenadione) — Instituto Mexicano del Seguro Social.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
phytomenadione TARGET	phytomenadione	Instituto Mexicano del Seguro Social	phase 2		Alpha-synuclein
Destriol	ESTRIOL		marketed	estriol	Corticosteroid-binding globulin, Olfactory receptor 51E2, Alpha-synuclein	2000-01-01
Rocephin	ceftriaxone	Generic (originally Roche)	marketed	Cephalosporin antibiotic (third-generation)	Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A	1984-12-21
Menadion	MENADIONE	Eli Lilly	marketed	Vitamin D [EPC]	Aldehyde oxidase, Alpha-synuclein, Dual specificity phosphatase Cdc25A	1982-01-01
Rifadin	Rifampicin	Sanofi Aventis Us	marketed	Rifamycin Antibacterial [EPC]	Solute carrier organic anion transporter family member 1A2, ATP-binding cassette sub-family G member 2, Alpha-synuclein	1971-01-01
Bromocriptin	Bromocriptin	University Hospital, Bonn	marketed		5-hydroxytryptamine receptor 6, Alpha-synuclein, D(1B) dopamine receptor
Testosteron	Testosteron	Gulhane School of Medicine	marketed		Corticosteroid-binding globulin, Alpha-synuclein, Lanosterol 14-alpha demethylase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). phytomenadione — Competitive Intelligence Brief. https://druglandscape.com/ci/phytomenadione. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing